Chara Papadaki

Irakleion, ESYE43 71500, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

A Rare Case of a Concurrent Mandibular Odontogenic Keratocyst and Oral Rhabdomyosarcoma in a Young Cat.

A Rare Case of a Concurrent Mandibular Odontogenic Keratocyst and Oral Rhabdomyosarcoma in a Young Cat.

Journal: Journal of veterinary dentistry

Published: April 02, 2026

MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non-Small Cell Lung Cancer.

MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non-Small Cell Lung Cancer.

Journal: Cancers

Published: June 13, 2025

LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer.

LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer.

Journal: Cancers

Published: April 07, 2024

Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer.

Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer.

Journal: Frontiers in molecular biosciences

Published: April 06, 2024

Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Journal: PloS one

Published: November 09, 2023

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.

Journal: PloS one

Published: November 09, 2023

Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.

Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.

Journal: Breast cancer research : BCR

Published: July 22, 2022

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab.

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab.

Journal: Cancers

Published: July 12, 2022

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Journal: PloS one

Published: May 19, 2022

TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications.

TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications.

Journal: Cancers

Published: December 20, 2021

A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer.

A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer.

Journal: Cells

Published: July 07, 2021

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy.

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy.

Journal: Cancer management and research

Published: June 17, 2021

Showing 1-12 of 32

Last Updated: 09/26/2026